{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss-of-function mutations in PINK1 cause parkinsonism in humans and mitochondrial dysfunction in model organisms.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as loss-of-function leading to parkinsonism and mitochondrial dysfunction."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses cellular models to investigate the effects of PINK1 mutations on mitochondrial function and Parkin recruitment, which are relevant to the disease's molecular basis.",
          "judgment": "Yes",
          "reasoning": "The cellular assays effectively model the disease pathogenesis/mechanism by assessing mitochondrial function and protein-protein interactions.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of cellular assays to test the effects of the L347P mutation on PINK1 stability and function, including its ability to recruit Parkin to mitochondria.",
          "judgment": "Yes",
          "reasoning": "The assays used are valid as they directly assess the functional consequences of the L347P mutation on PINK1's role in mitochondrial maintenance and Parkin recruitment."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The L347P patient mutant of PINK1 is found to be unstable and fails to reconstitute YFP-Parkin recruitment to depolarized mitochondria.",
          "judgment": "Yes",
          "reasoning": "The functional evidence supports the pathogenicity of the L347P variant, as it disrupts the normal function of PINK1 and its interaction with Parkin."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The L347P variant in PINK1 was found to be unstable and unable to support the normal function of recruiting Parkin to mitochondria, consistent with a very strong pathogenic effect."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "168"
        },
        "variant_string_id": "PINK1 A168P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss-of-function mutations in PINK1 cause parkinsonism in humans and mitochondrial dysfunction in model organisms.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as loss-of-function leading to parkinsonism and mitochondrial dysfunction."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses cellular models to investigate the effects of PINK1 mutations on mitochondrial function and Parkin recruitment, which are relevant to the disease's molecular basis.",
          "judgment": "Yes",
          "reasoning": "The cellular assays effectively model the disease pathogenesis/mechanism by assessing mitochondrial function and protein-protein interactions.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of cellular assays to test the effects of the A168P mutation on PINK1 stability and function, including its ability to recruit Parkin to mitochondria.",
          "judgment": "Yes",
          "reasoning": "The assays used are valid as they directly assess the functional consequences of the A168P mutation on PINK1's role in mitochondrial maintenance and Parkin recruitment."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Of the patient mutations that exhibited stable expression, A168P failed to reconstitute YFP-Parkin recruitment at 3 h.",
          "judgment": "Yes",
          "reasoning": "The functional evidence supports the pathogenicity of the A168P variant, as it disrupts the normal function of PINK1 and its interaction with Parkin."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The A168P variant in PINK1 was found to disrupt the normal function of recruiting Parkin to mitochondria, consistent with a moderate pathogenic effect."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "H",
          "alt": "Q",
          "position": "271"
        },
        "variant_string_id": "PINK1 H271Q"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss-of-function mutations in PINK1 cause parkinsonism in humans and mitochondrial dysfunction in model organisms.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as loss-of-function leading to parkinsonism and mitochondrial dysfunction."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses cellular models to investigate the effects of PINK1 mutations on mitochondrial function and Parkin recruitment, which are relevant to the disease's molecular basis.",
          "judgment": "Yes",
          "reasoning": "The cellular assays effectively model the disease pathogenesis/mechanism by assessing mitochondrial function and protein-protein interactions.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of cellular assays to test the effects of the H271Q mutation on PINK1 stability and function, including its ability to recruit Parkin to mitochondria.",
          "judgment": "Yes",
          "reasoning": "The assays used are valid as they directly assess the functional consequences of the H271Q mutation on PINK1's role in mitochondrial maintenance and Parkin recruitment."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Of the patient mutations that exhibited stable expression, H271Q failed to reconstitute YFP-Parkin recruitment at 3 h.",
          "judgment": "Yes",
          "reasoning": "The functional evidence supports the pathogenicity of the H271Q variant, as it disrupts the normal function of PINK1 and its interaction with Parkin."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The H271Q variant in PINK1 was found to disrupt the normal function of recruiting Parkin to mitochondria, consistent with a moderate pathogenic effect."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss-of-function mutations in PINK1 cause parkinsonism in humans and mitochondrial dysfunction in model organisms.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as loss-of-function leading to parkinsonism and mitochondrial dysfunction."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses cellular models to investigate the effects of PINK1 mutations on mitochondrial function and Parkin recruitment, which are relevant to the disease's molecular basis.",
          "judgment": "Yes",
          "reasoning": "The cellular assays effectively model the disease pathogenesis/mechanism by assessing mitochondrial function and protein-protein interactions.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of cellular assays to test the effects of the G309D mutation on PINK1 stability and function, including its ability to recruit Parkin to mitochondria.",
          "judgment": "Yes",
          "reasoning": "The assays used are valid as they directly assess the functional consequences of the G309D mutation on PINK1's role in mitochondrial maintenance and Parkin recruitment."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "G309D only partially reconstituted YFP-Parkin recruitment (30.7616.7%).",
          "judgment": "Yes",
          "reasoning": "The functional evidence supports the pathogenicity of the G309D variant, as it partially disrupts the normal function of PINK1 and its interaction with Parkin."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G309D variant in PINK1 partially disrupts the normal function of recruiting Parkin to mitochondria, consistent with a supporting pathogenic effect."
    }
  ]
}